SKYBIOTECH HEALTHCARE LIMITED

BSE: SKYBIOTECH512036ISIN INE393H01016

Consumer Discretionary
Other Textile Products

Share price

₹116.50-0.50 (-0.43%)

as of 23 Oct 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹218.20
52W low: ₹113.90
Off 52W high: -46.61%
1M return: +1.26%
3M return: -27.26%
6M return: -16.13%
1Y return: -41.68%
20D avg volume: 76
50 DMA: ₹128.82
200 DMA: ₹160.85

Key ratios Consolidated

Market cap: ₹22.31 Cr
Current price: ₹116.50
52W high / low: ₹218.20 / ₹113.90
Face value: ₹10.00
P/E: -13.34
P/B: 2.79
EPS (TTM): ₹-8.74
Book value / share: ₹41.74
ROE: —
ROCE: -9.40%
Operating margin: —
Net margin: —
Debt / equity: 0.91
Net debt: ₹9.01 Cr
Interest cover: -82.50
Dividend yield: —
Dividend / share (TTM): —
Payout: —
Cash conversion cycle: 54.5 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	0.49	1.83	0.96	1.92	2.39	1.02	2.52	1.60	2.39	—
	0.06	0.15	0.08	0.04	0.04	0.18	0.15	0.04	0.04	—
	0.55	1.98	1.04	1.96	2.42	0.83	2.67	1.64	2.42	—
	1.13	2.84	1.53	2.27	2.44	2.02	3.08	1.83	2.44	—
	0.30	0.97	0.55	0.33	1.24	0.91	0.86	0.47	1.24	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	0.00	—
	0.39	0.43	0.36	0.57	0.39	0.42	0.66	0.37	0.39	—
	0.00	0.01	0.00	0.01	0.01	0.23	0.11	0.14	0.01	—
	0.11	0.12	0.12	0.12	0.12	0.15	0.14	0.13	0.12	—
	0.46	0.94	0.49	0.64	0.84	0.89	0.87	0.96	0.84	—
	-0.57	-0.85	-0.48	-0.31	-0.02	-1.18	-0.41	-0.19	-0.02	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	-0.57	-0.85	-0.48	-0.31	-0.02	-1.18	-0.41	-0.19	-0.02	—
	0.00	0.55	0.00	0.00	0.00	-0.10	0.02	0.06	0.00	—
	-0.57	-0.30	-0.48	-0.31	-0.02	-1.08	-0.40	-0.25	-0.02	—
	-2.56	-2.96	-1.29	-1.29	0.25	-13.68	-3.06	5.46	0.25	—
Key metrics
	-0.46	-0.72	-0.36	-0.18	0.11	-0.80	-0.16	0.08	0.11	—
	-93.90%	-39.30%	-37.50%	-9.40%	4.60%	-78.40%	-6.30%	5.00%	4.60%	—
	-116.30%	-16.40%	-50.00%	-16.10%	-0.80%	-105.90%	-15.90%	-15.60%	-0.80%	—
	—	-4.80%	—	-1.70%	—	-5.40%	—	—	—	—
	-79.50%	79.40%	-61.90%	20.00%	0.00%	—	—	—	—	—
	-2,750.00%	72.20%	-20.00%	-24.00%	0.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	5.20	7.10	7.05	—
	0.33	0.31	0.38	—
	5.53	7.40	7.43	—
	7.77	9.07	9.86	—
	2.15	3.09	3.67	—
	0.00	0.00	0.00	—
	1.75	1.76	1.96	—
	0.02	0.02	0.01	—
	0.47	0.48	0.54	—
	2.53	2.90	3.73	—
	-2.21	-1.67	-2.43	—
	0.00	0.00	0.00	—
	-2.21	-1.67	-2.43	—
	0.55	-0.55	-0.06	—
	-1.66	-1.12	-2.37	—
	-8.10	-6.70	-14.19	—
Key metrics
	-1.72	-1.17	-1.88	—
	-33.08%	-16.50%	-26.70%	—
	-31.92%	-15.80%	-33.60%	—
	—	-9.40%	-13.80%	—
	-30.94%	0.70%	—	—
	—	52.70%	—	—
	—	-1.52	-1.04	—
	—	1.36	0.44	—
	—	0.91	0.68	—
	—	9.01	7.47	—
	—	54.5	71.9	—
Balance sheet
	—	19.44	20.10	—
	—	1.33	1.92	—
	—	-0.59	-0.27	—
	—	1.11	0.42	—
	—	0.80	1.59	—
	—	—	0.16	—
	—	8.37	8.85	—
	—	0.85	0.62	—
	—	1.94	2.55	—
	—	8.42	7.20	—
	—	0.17	0.19	—
	—	8.25	7.01	—
	—	9.25	10.54	—
Cash flow
	—	-1.52	-1.04	—
	—	0.02	-9.63	—
	—	1.17	1.24	—
	—	0.00	0.00	—

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24
Income statement
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	0.00	—
	0.05	0.02	0.00	0.02	0.03	0.20	0.00	0.02	0.35	—
	0.05	0.02	0.00	0.02	0.03	-0.20	0.00	0.02	0.35	—
	0.05	0.02	0.06	0.00	0.04	0.04	0.01	0.01	0.04	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	0.00	—
	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00	—
	0.04	0.01	0.06	0.00	0.04	0.04	0.00	0.01	0.04	—
	0.00	0.01	-0.06	0.01	-0.01	-0.24	-0.01	0.01	0.31	—
	0.00	0.00	0.00	0.00	0.00	0.00	—	—	0.00	—
	0.00	0.01	-0.06	0.01	-0.01	-0.24	-0.01	0.01	0.31	—
	0.00	0.00	0.00	0.00	0.00	-0.04	—	0.00	0.06	—
	0.00	0.01	-0.06	0.01	-0.01	-0.20	-0.01	0.01	0.25	—
	0.46	-1.34	0.30	-0.41	0.27	-9.06	-1.03	6.79	0.27	—
Key metrics
	0.00	0.01	-0.06	0.01	-0.01	-0.24	-0.01	0.01	0.31	—
	—	—	—	—	—	—	—	50.00%	—	—
	—	—	—	—	—	—	—	50.00%	—	—
	—	0.10%	—	0.10%	—	-2.00%	—	—	—	—
	—	—	—	-100.00%	—	—	—	—	—	—
	100.00%	105.00%	-500.00%	0.00%	-104.00%	—	—	—	—	—

Metric	TTM	FY26	FY25	FY24
Income statement
	0.00	0.00	0.00	—
	0.09	0.07	0.18	—
	0.09	0.07	0.18	—
	0.13	0.13	0.11	—
	0.00	0.00	0.00	—
	0.00	0.00	0.00	—
	0.00	0.01	0.01	—
	0.00	0.00	0.00	—
	0.00	0.00	0.00	—
	0.11	0.11	0.09	—
	-0.04	-0.06	0.08	—
	0.00	0.00	0.00	—
	-0.04	-0.06	0.08	—
	0.00	0.00	0.02	—
	-0.04	-0.06	0.06	—
	-0.99	-1.18	-1.50	—
Key metrics
	-0.04	-0.06	0.08	—
	-44.44%	—	—	—
	-44.44%	—	—	—
	—	-0.50%	0.70%	—
	—	-200.00%	—	—
	—	0.00	0.30	—
	—	0.00	5.00	—
	—	0.00	0.00	—
	—	-0.01	0.02	—
Balance sheet
	—	12.42	12.62	—
	—	0.17	0.15	—
	—	0.01	-0.02	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	—	0.16	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.75	0.67	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	0.00	0.00	—
	—	11.55	11.78	—
Cash flow
	—	0.00	0.30	—
	—	0.02	-9.30	—
	—	0.00	0.55	—
	—	0.00	0.00	—

Compounded growth

Standalone

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): +100.00%
Profit YoY (TTM): +80.95%

Consolidated

Sales CAGR 3Y: —
Sales CAGR 5Y: —
Profit CAGR 3Y: —
Profit CAGR 5Y: —
Sales YoY (TTM): -30.94%
Profit YoY (TTM): +5.14%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 63.47%

Quarter	September 2026	June 2026	March 2026
Promoter %	63.47%	63.47%	63.47%

Holder	Type	Holding	Previous	Change
PRAKASHCHANDRA RATHI	Promoter	45.16%	45.16%	0.00%
POONAM PRAKASH RATHI	Promoter	13.01%	13.01%	0.00%
RAJLAXMI GANESH TOTALA	Promoter Group	5.22%	5.22%	0.00%
GANESH SHIVPRASAD LAHOTI	Public	4.44%	4.44%	0.00%
SANGITA ASHISH RATHI	Public	3.26%	3.26%	0.00%
KAUSTUBH ASHISH RATHI	Public	3.26%	3.26%	0.00%
SMITA SHIVPRASAD LAHOTI	Public	2.09%	2.09%	0.00%
ALKA PRAVIN JOSHI .	Public	1.96%	1.96%	0.00%
RAKESH SATYA NARAYAN RATHI	Public	1.39%	1.39%	0.00%
PANKTI CHETAN BHANSALI	Public	1.31%	1.31%	0.00%
PAVAN MADANLAL MALPANI	Public	1.31%	1.31%	0.00%
SHANKAR SONAR	Public	1.09%	1.09%	0.00%
HARSHALA RAJESH KOTHARI	Public	1.07%	1.11%	-0.04%
RAMSWROOP KALYAN MAL SOMANI .	Public	1.05%	1.05%	0.00%
YOGESH NANDLAL CHANDAK	Promoter	0.08%	0.08%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
K.P.R. Mill Ltd.	35,029	1,024.80	38.39	20.20%	+4.20% TTM	+10.65% TTM	-5.29%
WELSPUN LIVING LIMITED	19,816	209.75	69.24	6.20%	-3.26% TTM	-47.71% TTM	+63.80%
Vardhman Textiles Limted	14,489	500.35	16.85	8.20%	+3.29% TTM	+0.64% TTM	+14.31%
Trident Ltd	10,437	20.48	26.41	10.50%	-2.45% TTM	-9.51% TTM	-28.72%
Indo Count Industries Ltd	7,811	394.40	51.77	9.80%	+5.30% TTM	-26.76% TTM	+39.81%
GARWARE TECHNICAL FIBRES LIMITED	7,233	740.75	34.42	19.60%	+4.64% TTM	-11.67% TTM	-4.91%
Kusumgar Limited	5,762	548.80	—	—	—	—	—
Sanathan Textiles Limited	4,211	498.90	69.33	6.40%	+48.53% TTM	-59.72% TTM	+1.92%
Filatex India Ltd.	4,068	91.60	21.28	16.70%	+0.22% TTM	+34.38% TTM	+63.98%
Alok Industries Ltd.	4,022	8.10	-5.31	-3.10%	+6.01% TTM	-11.07% TTM	-54.24%
Jindal Worldwide Ltd.	3,550	35.41	41.88	13.80%	-1.72% TTM	+12.65% TTM	-4.99%
Nitin Spinners Ltd. S	3,386	602.30	15.98	14.30%	-0.01% TTM	+21.53% TTM	+81.72%
Raymond Lifestyle Limited	3,113	510.95	71.73	2.80%	+9.18% TTM	+4.38% TTM	-57.65%
Sangam (India) Ltd	2,909	579.00	23.94	12.10%	+11.90% TTM	+518.32% TTM	+33.80%
Ganesha Ecosphere Limited	2,614	975.70	46.28	5.60%	+6.96% TTM	-38.14% TTM	-19.77%
Sportking India Ltd. S	2,569	202.15	15.89	14.20%	+5.56% TTM	+43.54% TTM	+93.70%
Siyaram Silk Mills Ltd.	2,174	479.10	9.16	21.40%	+14.08% TTM	+24.71% TTM	-36.24%
AAYUSH ART AND BULLION LIMITED S	2,000	1,306.20	253.63	17.60%	—	—	+31.27%
Indo Rama Synthetics (India) Ltd.	1,948	74.60	9.24	27.50%	-4.69% TTM	+48.44% TTM	+9.21%
Bombay Dyeing & Mfg. Co. Ltd.	1,794	86.85	88.84	1.90%	-2.55% TTM	-95.87% TTM	-50.11%
Pashupati Cotspin Limited	1,646	104.27	104.55	12.10%	—	—	+32.92%
Ruby Mills Ltd. S	1,541	460.70	35.55	6.10%	+43.42% TTM	-4.87% TTM	+106.92%
AYM Syntex Limited	1,329	226.15	70.83	6.30%	-5.36% TTM	+223.62% TTM	+28.82%
Raj Rayon Industries Limited S	1,164	20.93	33.22	16.30%	+23.88% TTM	+48.95% TTM	-16.01%
United Polyfab Gujarat Limited	1,129	49.18	—	22.00%	—	—	—
SKYBIOTECH HEALTHCARE LIMITED	22	116.50	-13.34	-9.40%	-30.94% TTM	+5.14% TTM	-41.68%

Filings & corporate actions

Recent announcements

Certificate under Regulation 74(5) of SEBI (DP)Regulation 2018 for the quarter ended on 30th September, 202616 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Submission of Scrutinizer Report for the 43rd Annual General Meeting of Company held on 30th September, 20261 Oct 2026 · AGM/EGM / AGM
Intimation of Trading Window closure to declared financial results for the Quarter ended on 30th September, 20261 Oct 2026 · Insider Trading / SAST / Closure of Trading Window
Proceeding of 43rd Annual general Meeting of members of Skybiotech Healthcare Limited30 Sep 2026 · AGM/EGM / AGM
Outcome of 43rd Annual General Meeting of of SKYBIOTECH HEALTHCARE LIMITED held on 30th September, 202630 Sep 2026 · AGM/EGM / AGM
Intimation of Notice of Annual General Meeting propose to be held on 30th September, 20265 Sep 2026 · AGM/EGM / AGM
Submission of Annual Report for Financial Year 2025-20265 Sep 2026 · Others / Reg. 34 (1) Annual Report
Un-Audited Financial Results for the quarter ended on 30th June 202614 Aug 2026 · Result / Financial Results
Outcome of Board Meeting dated 14th August, 2026 to considered and approved the Un-audited Financial Results of Company for the quarter ended on 30th June, 202614 Aug 2026 · Board Meeting / Outcome of Board Meeting
Skybiotech Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Un-Audited financial ....11 Aug 2026 · Board Meeting / Board Meeting
Compliance Certificate under Regulation 74(5) of SEBI (DP) Regulation19 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of Trading Window Closure to consider and approve un-audited financial results for the quarter ended on 30th June 202627 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Submission of Financial Results for the Quarter and Year ended on 31st March 202630 May 2026 · Result / Financial Results
Submission of Outcome of board meeting and Financial Results for the quarter and year ended on 31st March 202630 May 2026 · Board Meeting / Outcome of Board Meeting
Skybiotech Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 30/05/2026 ,inter alia, to consider and approve Approval of Audited Results ....26 May 2026 · Board Meeting / Board Meeting
Format of Initial Disclosure to be made by an entity identified as a Large Corporate. <table border=''1px''><tr> <td>Sr. No.</td> <td>Particulars</td> <td>Details</td> ....30 Apr 2026 · Others / Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A
Certificate under Reg. 74(5) of SEBI (DP) Regulation, 2018 received from RTA9 Apr 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimation of Trading window closure to consider and approve Audited Financials for the Quarter and year ended on 31st March 202630 Mar 2026 · Insider Trading / SAST / Closure of Trading Window
Submission of Un-Audited Financial Results for the Quarter ended on 31st December, 202514 Feb 2026 · Result / Financial Results
Outcome of Board Meeting to Considered and Approved Un-Audited Financials for the Quarter ended on 31st December, 202514 Feb 2026 · Board Meeting / Outcome of Board Meeting
Skybiotech Healthcare Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/02/2026 ,inter alia, to consider and approve Approval of Unaudited ....11 Feb 2026 · Board Meeting / Board Meeting
Compliance certificate Under Reg. 74(5) of SEBI (DP) Regulation, 2018 for the quarter ended on 31st December, 202516 Jan 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Intimidation of initiation of Trading Window Closure for the Quarter ended on 31st December, 202527 Dec 2025 · Insider Trading / SAST / Closure of Trading Window
Revised Un-audited Financial Results for the quarter ended on 30th September, 202520 Nov 2025 · Result / Financial Results
Un-Audited Financial Results for quarter ended on 30th September 202515 Nov 2025 · Result / Financial Results
Outcome of Board Meeting held on 14th November, 2025 to Considered and approved Un-audited Financials Results for the quarter ended on 30th September, 202515 Nov 2025 · Board Meeting / Outcome of Board Meeting
Kapil Cotex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/11/2025 ,inter alia, to consider and approve Consideration and approval of Unaudited ....11 Nov 2025 · Board Meeting / Board Meeting
Receipt of Approval of Registrar of Company (ROC) for Change of Name from Kapil Cotex Limited to Skybiotech Healthcare Limited8 Nov 2025 · Company Update / Change of Name
Compliance Certificate Under Regulation 74(5) of SEBI (DP) Regulation for the Quarter ended on 30th September, 202510 Oct 2025 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Scrutinizer Report of AGM26 Sep 2025 · AGM/EGM / AGM
Intimation regarding Trading Window Closure for approval of unaudited financial results of Company for the Quarter and half year ended 30th September, 202525 Sep 2025 · Insider Trading / SAST / Closure of Trading Window
Proceeding of 42nd Annual General Meeting of Kapil Cotex Limited25 Sep 2025 · Company Update / Meeting Updates
Outcome of 42nd Annual General Meeting of Kapil Cotex Limited25 Sep 2025 · AGM/EGM / AGM
Annual Report for Financial Year 2024-2529 Aug 2025 · Others / Reg. 34 (1) Annual Report
Resignation of Mr. Santosh Shivaji Pimparkar-(DIN: 08466723) Executive Director of Company28 Aug 2025 · Company Update / Resignation of Director
Outcome of Board Meeting dated 28th August, 202528 Aug 2025 · Board Meeting / Outcome of Board Meeting
Kapil Cotex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 28/08/2025 ,inter alia, to consider and approve the Proposal on Change of Name ....23 Aug 2025 · Board Meeting / Board Meeting
Financials Results for the quarter ended on 30thu June 202514 Aug 2025 · Result / Financial Results
Outcome of Board Meeting to considered and approve An-audited Financials Results of Company for the Quarter ended 30th June 202514 Aug 2025 · Board Meeting / Outcome of Board Meeting
Kapil Cotex Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2025 ,inter alia, to consider and approve Approval of Unaudited Financials ....11 Aug 2025 · Board Meeting / Board Meeting

Board meetings

14 Aug 2026 Board Meeting - Financial Results